scorecardresearch
Add as a preferred source on Google
Friday, December 12, 2025
TopicAlexion Pharmaceuticals

Topic: Alexion Pharmaceuticals

AstraZeneca plans post-Covid growth with $39 billion deal with Alexion Pharmaceuticals

The proposed cash-and-stock acquisition will add treatments for uncommon blood and immunological disorders to the portfolio of the Cambridge-based drugmaker.

On Camera

IndiGo cancellations made TV news do the unexpected — question the Modi government

Republic TV was the harshest of them all: “The (civil aviation) minister has done a bad job,” said prime time anchor Arnab Goswami.

IndiGo’s profits dipped, most airlines sunk into losses last fiscal even as flier numbers soared

Despite growing passenger volume, 11 out of 14 carriers reported losses in 2023-24. IndiGo recorded profit of Rs 8,167 crore, which reduced to Rs 7.253 crore in 2024-25.

Dubai Tejas crash revives focus on advanced, fully automated safety systems

Dubai airshow crash & pilot death have rekindled concerns over pilot safety, and need for smarter automated systems that can step in when G-forces, temporary loss of consciousness hit the pilot.

Asim Munir & Pakistan’s Failed Marshal Doctrine

None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.